156 related articles for article (PubMed ID: 37554496)
1. Inhaled corticosteroids and adverse outcomes among chronic obstructive pulmonary disease patients with community-acquired pneumonia: a population-based cohort study.
Basille D; Wang L; Thomsen RW; Menon J; Shetty N; Duhaut P; Andrejak C; Jounieaux V; Sørensen HT
Front Med (Lausanne); 2023; 10():1184888. PubMed ID: 37554496
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
3. Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia.
Singanayagam A; Chalmers JD; Akram AR; Hill AT
Eur Respir J; 2011 Jul; 38(1):36-41. PubMed ID: 21429980
[TBL] [Abstract][Full Text] [Related]
4. Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study.
Lee JH; Park YH; Kang DR; Lee SJ; Lee MK; Kim SH; Yong SJ; Lee WY
Int J Chron Obstruct Pulmon Dis; 2020; 15():3397-3406. PubMed ID: 33402820
[TBL] [Abstract][Full Text] [Related]
5. Inhaled Corticosteroids May Not Affect the Clinical Outcomes of Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.
Chang MS; Cho IS; Yu I; Park S; Lee SJ; Yong SJ; Lee WY; Kim SH; Lee JH
Tuberc Respir Dis (Seoul); 2024 Feb; ():. PubMed ID: 38369876
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD.
Tøttenborg SS; Lange P; Johnsen SP; Nielsen H; Ingebrigtsen TS; Thomsen RW
Respir Med; 2016 Oct; 119():160-167. PubMed ID: 27692139
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease.
Park JW; Hong Y; Rhee CK; Choi HS; Kim K; Yoo KH; Jung KS; Park JH
Int J Chron Obstruct Pulmon Dis; 2023; 18():733-743. PubMed ID: 37159577
[TBL] [Abstract][Full Text] [Related]
8. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis.
Loke YK; Kwok CS; Wong JM; Sankaran P; Myint PK
Int J Clin Pract; 2013 May; 67(5):477-87. PubMed ID: 23574107
[TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
Thornton Snider J; Luna Y; Wong KS; Zhang J; Chen SS; Gless PJ; Goldman DP
Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
[TBL] [Abstract][Full Text] [Related]
11. The effect of inhaled corticosteroids in the outcomes of community-acquired pneumonia: ICCAP study (TURKCAP Database).
Baha A; Kokturk N; Bahcecioglu SN; Yapar D; Aksakal N; Gündüz C; Tasbakan S; Sayiner A; Coskun AS; Durmaz F; Cilli A; Celenk B; Kılınc O; Salman S; Hazar A; Tokgoz F
Clin Respir J; 2020 Apr; 14(4):397-404. PubMed ID: 31908143
[TBL] [Abstract][Full Text] [Related]
12. THE PARADOXICAL EFFECT ON PNEUMONIA OF CHRONIC INHALED CORTICOSTEROIDS.
Sibila O; Anzueto A; Restrepo MI
Clin Pulm Med; 2013 Jan; 20(1):. PubMed ID: 24244086
[TBL] [Abstract][Full Text] [Related]
13. Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance.
Sibila O; Laserna E; Mortensen EM; Anzueto A; Restrepo MI
Respir Care; 2013 Sep; 58(9):1489-94. PubMed ID: 23345471
[TBL] [Abstract][Full Text] [Related]
14. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
[TBL] [Abstract][Full Text] [Related]
15. Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.
Chen D; Restrepo MI; Fine MJ; Pugh MJ; Anzueto A; Metersky ML; Nakashima B; Good C; Mortensen EM
Am J Respir Crit Care Med; 2011 Aug; 184(3):312-6. PubMed ID: 21512168
[TBL] [Abstract][Full Text] [Related]
16. Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study.
Bloom CI; Douglas I; Usmani OS; Quint JK
Int J Chron Obstruct Pulmon Dis; 2020; 15():701-710. PubMed ID: 32308379
[TBL] [Abstract][Full Text] [Related]
17. Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring
Heerfordt CK; Eklöf J; Sivapalan P; Ingebrigtsen TS; Biering-Sørensen T; Harboe ZB; Koefod Petersen J; Andersen CØ; Boel JB; Bock AK; Mathioudakis AG; Hurst JR; Kolekar S; Johansson SL; Bangsborg JM; Jarløv JO; Dessau RB; Laursen CB; Perch M; Jensen JS
Int J Chron Obstruct Pulmon Dis; 2023; 18():373-384. PubMed ID: 36974273
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
[TBL] [Abstract][Full Text] [Related]
19. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroids in COPD and the risk of lung cancer.
Lee YM; Kim SJ; Lee JH; Ha E
Int J Cancer; 2018 Nov; 143(9):2311-2318. PubMed ID: 29943812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
